Precision Optics Appoints Buell Duncan to Board of Directors; Dr. Richard Miles Retires from Board
Precision Optics (NASDAQ: POCI), a designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, has announced key changes to its Board of Directors. Buell Duncan, former Chief Marketing Officer of IBM Software, Cloud, Data and AI businesses, has been appointed to the board, bringing extensive executive leadership experience from his 28-year tenure at IBM (1992-2020).
Duncan currently serves as a Portfolio Advisor and Partner with Iron Gate Capital, a venture capital firm focused on early-growth B2B technology companies. He is also a Board observer of SHARE Mobility and Respondology, and a Strategic Advisor to several technology companies.
Concurrent with Duncan's appointment, Dr. Richard Miles, who joined the board in November 2005, has announced his retirement after nearly 20 years of service.
Precision Optics (NASDAQ: POCI), un designer e produttore di strumenti ottici avanzati per le industrie mediche e della difesa/aerospaziale, ha annunciato importanti cambiamenti nel suo Consiglio di Amministrazione. Buell Duncan, ex Chief Marketing Officer delle divisioni Software, Cloud, Data e AI di IBM, è stato nominato nel consiglio, portando con sé una vasta esperienza di leadership esecutiva derivante dai suoi 28 anni di carriera in IBM (1992-2020).
Duncan attualmente ricopre il ruolo di Portfolio Advisor e Partner presso Iron Gate Capital, una società di venture capital focalizzata su aziende tecnologiche B2B in fase di crescita. È anche osservatore del Consiglio di SHARE Mobility e Respondology, e Consulente Strategico per diverse aziende tecnologiche.
In concomitanza con la nomina di Duncan, Dr. Richard Miles, che è entrato nel consiglio nel novembre 2005, ha annunciato il suo ritiro dopo quasi 20 anni di servizio.
Precision Optics (NASDAQ: POCI), un diseñador y fabricante de instrumentos ópticos avanzados para las industrias médica y de defensa/aeroespacial, ha anunciado cambios clave en su Junta Directiva. Buell Duncan, ex Director de Marketing de las divisiones de Software, Nube, Datos y AI de IBM, ha sido nombrado para la junta, aportando una amplia experiencia en liderazgo ejecutivo de sus 28 años en IBM (1992-2020).
Duncan actualmente se desempeña como Asesor de Portafolio y Socio en Iron Gate Capital, una firma de capital de riesgo enfocada en empresas tecnológicas B2B en crecimiento. También es observador de la Junta de SHARE Mobility y Respondology, y Asesor Estratégico de varias empresas tecnológicas.
Concurrentemente con la designación de Duncan, Dr. Richard Miles, quien se unió a la junta en noviembre de 2005, ha anunciado su jubilación tras casi 20 años de servicio.
Precision Optics (NASDAQ: POCI)는 의료 및 방위/항공 우주 산업을 위한 고급 광학 기기 설계 및 제조업체로, 이사회에 중요한 변화를 발표했습니다. Buell Duncan은 IBM 소프트웨어, 클라우드, 데이터 및 AI 사업부의 전 최고 마케팅 책임자로, IBM에서 28년간 근무한 경영진 리더십 경험을 가지고 이사회에 합류했습니다 (1992-2020).
Duncan은 현재 Iron Gate Capital의 포트폴리오 어드바이저이자 파트너로 활동하고 있으며, 이 회사는 초기 성장 단계의 B2B 기술 기업에 집중하는 벤처 캐피탈 회사입니다. 그는 또한 SHARE Mobility 및 Respondology의 이사회 관찰자이자 여러 기술 기업의 전략 고문으로 활동하고 있습니다.
Duncan의 임명과 동시에 Dr. Richard Miles는 2005년 11월에 이사회에 합류한 이후 거의 20년의 서비스 후 은퇴를 발표했습니다.
Precision Optics (NASDAQ: POCI), un concepteur et fabricant d'instruments optiques avancés pour les industries médicale et de défense/aérospatiale, a annoncé des changements clés au sein de son Conseil d'Administration. Buell Duncan, ancien directeur marketing des activités Software, Cloud, Data et AI d'IBM, a été nommé au conseil, apportant une vaste expérience en leadership exécutif acquise au cours de ses 28 années chez IBM (1992-2020).
Duncan est actuellement conseiller en portefeuille et partenaire chez Iron Gate Capital, une société de capital-risque axée sur les entreprises technologiques B2B en phase de croissance. Il est également observateur au Conseil de SHARE Mobility et Respondology, et conseiller stratégique pour plusieurs entreprises technologiques.
En même temps que la nomination de Duncan, Dr. Richard Miles, qui a rejoint le conseil en novembre 2005, a annoncé sa retraite après près de 20 ans de service.
Precision Optics (NASDAQ: POCI), ein Designer und Hersteller fortschrittlicher optischer Instrumente für die medizinische sowie die Verteidigungs- und Luftfahrtindustrie, hat wichtige Änderungen in seinem Vorstand angekündigt. Buell Duncan, ehemaliger Chief Marketing Officer der IBM-Geschäfte für Software, Cloud, Daten und KI, wurde in den Vorstand berufen und bringt umfassende Führungserfahrung aus seiner 28-jährigen Tätigkeit bei IBM (1992-2020) mit.
Duncan ist derzeit als Portfolio Advisor und Partner bei Iron Gate Capital tätig, einer Risikokapitalgesellschaft, die sich auf wachstumsstarke B2B-Technologieunternehmen konzentriert. Er ist auch Beobachter im Vorstand von SHARE Mobility und Respondology sowie strategischer Berater für mehrere Technologieunternehmen.
Parallel zu Duncans Ernennung hat Dr. Richard Miles, der im November 2005 in den Vorstand eintrat, nach fast 20 Jahren Dienstzeit seinen Rücktritt angekündigt.
- Addition of experienced executive with strong marketing and technology background
- Strategic expertise in software, cloud, and AI sectors
- Current involvement in venture capital and advisory roles brings valuable network
- Loss of long-term technical expertise with Dr. Miles' retirement
GARDNER, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, is pleased to announce the appointment of Buell Duncan to its Board of Directors. Mr. Duncan brings decades of executive leadership and strategic expertise, further strengthening the Company's commitment to innovation and growth.
With an extensive career in the technology and business sectors, Mr. Duncan held senior leadership positions at a number of IBM global business units from 1992 through 2020 where he was instrumental in driving marketing, strategy, and business development initiatives. Most recently, he was Chief Marketing Officer of IBM Software, Cloud, Data and AI businesses. He currently is a Portfolio Advisor, and Limited Partner with Iron Gate Capital, a venture capital firm focused on early-growth B2B technology companies, a Board observer of SHARE Mobility and Respondology, and a Strategic Advisor to Geminos AI, Demand Spring and Pillir Software.
“We are thrilled to welcome Buell Duncan to our Board of Directors,” said Peter Woodward, Chairman of the Board of Precision Optics. “Buell’s experience building and leading sales and marketing teams for organizations both large and small will be valuable to POC as we work to capitalize on sizeable market opportunities.”
In connection with Buell Duncan’s appointment, Dr. Richard Miles has retired from the Board of Directors. Dr. Miles was initially appointed to Precision Optics’ Board in November 2005.
“I want to thank Dick for his commitment and contributions to POC over the past 20 years. We were fortunate to have a technical leader of Dick’s caliber serve on the Board, and we wish him the best in the future,” Mr. Woodward stated.
About Precision Optics Corporation
Founded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.
About Forward-Looking Statements
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including risks that the closing conditions for this offering will not be achieved, the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.
Company Contact:
PRECISION OPTICS CORPORATION
22 East Broadway
Gardner, Massachusetts 01440-3338
Telephone: 978-630-1800
Investor Contact:
LYTHAM PARTNERS, LLC
Robert Blum
Telephone: 602-889-9700
poci@lythampartners.com
FAQ
What experience does Buell Duncan bring to Precision Optics (POCI) board?
How long did Dr. Richard Miles serve on POCI's board before retiring?
What are Buell Duncan's current roles outside of POCI?
What industries does Precision Optics (POCI) serve?
